West Pharmaceutical Services (NYSE:WST – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and ...

West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

New Mexico Educational Retirement Board decreased its position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) ...

We recently published a list of These Were Last Week’s 10 Worst Performers. In this article, we are going to take a look at ...

West Pharmaceutical’s earnings results led to a 38% drop. Find out why WST stock could be worth watching for future rebounds ...

Shares of West Pharmaceutical Services Inc. rose 7.84% to $214.73 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.01% to ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its stock performance has been volatile, with annual returns of 66% in 2021, ...

West Pharmaceutical Services (WST) stock was upgraded to Buy at Deutsche Bank due to an attractive entry point post-selloff. Read more here.

Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...